Boehringer Ingelheim Rhinomune (EHV-1) Equine Vaccine 5 mL/5 Dose
For vaccination of healthy horses 3 months of age or older as an aid in the prevention of respiratory disease caused by equine herpesvirus type 1 (EHV-1).
**Ships Monday thru Thursday Only**
See our Pharmaceutical Quality Program for more info.
This product is non-returnable.
Boehringer Ingelheim Rhinomune (EHV-1) Equine Vaccine 5 mL/5 Dose
For vaccination of healthy horses 3 months of age or older as an aid in the prevention of respiratory disease caused by equine herpesvirus type 1 (EHV-1).
Disease Description
Primary infection with EHV-1 causes an acute respiratory disease characterized by nasal discharge, coughing, labored breathing, fever, slight loss of appetite, and depression. Annual outbreaks may occur among foals in areas with a large equine population. Clinical signs, occasionally persisting as long as 7 days, are generally more severe in young horses, and may be exacerbated by strenuous activity. Subclinical reinfection may also occur, with latent carriers the probable reservoir of EHV-1.
Directions and Dosage
Aseptically rehydrate the freeze-dried vaccine with the sterile diluent provided. Shake well. Administer 1 mL intramuscularly. Use entire contents when first opened.
Primary Vaccination: Healthy horses 3 months of age or older should receive 2 doses administered 3-4 weeks apart. Foals should be vaccinated when maternal antibodies have declined, generally at 3 months of age. If vaccinated earlier, foals should receive the 2-dose series after reaching 3 months of age. Pregnant mares should be vaccinated after the second month of pregnancy.
Revaccination: Revaccination every 3 months with a single dose is recommended.
Item Number | BOE114 |
---|---|
MPN | 139981 |
UPC | 087219007174 |
Weight | 5.000000 |
Brand | Boehringer Ingelheim |
Item Returns | This item can be returned |